Equity Research, Broker Reports, and media content on Verona Pharma plc Sponsored ADR

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Verona Pharma plc Sponsored ADR
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Verona Pharma plc Sponsored ADR

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Verona Pharma plc Sponsored ADR. We currently have 116 research reports from 7 professional analysts.

Date Source Announcement
02Feb21 07:00 GNW Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD
14Jan21 07:00 GNW Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
05Jan21 07:00 GNW Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
23Nov20 07:00 GNW Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank
09Nov20 07:00 GNW Verona Pharma Announces November 2020 Virtual Investor Conference Participation
29Oct20 07:00 GNW Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020
28Oct20 11:01 GNW Verona Pharma plc : Update on AIM Delisting
  • Frequency of research reports


  • Research reports on

    Verona Pharma plc Sponsored ADR

  • Providers covering

    Verona Pharma plc Sponsored ADR

Frequently asked questions